Malignant Ampulla of Vater Neoplasm — Trials

Malignant Ampulla of Vater Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: Minia University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07081360	Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer	recruiting	Phase 3	262	Minia UniversityOTHER	1	Sep 11, 2026	clinicaltrials
NCT05506943	A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)	active not recruiting	Phase 2 / Phase 3	168	Compass TherapeuticsINDUSTRY	1	Sep 2, 2026	clinicaltrials